Vivani Medical - 11 Year Stock Price History | VANI

Historical daily share price chart and data for Vivani Medical since 2014 adjusted for splits and dividends. The latest closing stock price for Vivani Medical as of February 03, 2025 is 1.17.
  • The all-time high Vivani Medical stock closing price was 566.40 on November 20, 2014.
  • The Vivani Medical 52-week high stock price is 7.80, which is 566.7% above the current share price.
  • The Vivani Medical 52-week low stock price is 1.01, which is 13.7% below the current share price.
  • The average Vivani Medical stock price for the last 52 weeks is 1.44.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Vivani Medical Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 1.2076 1.2000 1.2800 1.1700 1.1700 0.86%
2024 1.4238 1.0400 4.2200 1.0100 1.1600 13.73%
2023 1.1077 0.8951 1.5700 0.8600 1.0200 20.04%
2022 3.9880 5.4900 7.7100 0.8497 0.8497 -82.62%
2021 13.1624 7.0500 46.4400 4.2900 4.8900 -12.83%
2020 5.6752 17.6784 18.1500 2.1900 5.6100 -68.50%
2019 19.8324 23.6448 27.3600 15.6480 17.8080 -16.21%
2018 40.0224 48.2400 55.4400 17.5224 21.2520 -53.64%
2017 31.9170 47.2800 66.2400 23.1384 45.8400 -3.05%
2016 91.0390 134.4000 162.9600 42.2400 47.2800 -66.55%
2015 255.1692 243.6000 418.5600 112.8000 141.3600 -42.59%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.070B $0.000B
Vivani Medical Inc. is the combination of Nano Precision Medical, Inc. and Second Sight Medical Products, Inc. The Company leverages proprietary technologies to develop and commercialize drug and device implants that treat patients with chronic diseases. Vivani Medical Inc., formerly known as Second Sight Medical Inc., is based in EMERYVILLE, Calif.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $77.104B 29.67
Chugai Pharmaceutical (CHGCY) Japan $71.119B 28.07
Takeda Pharmaceutical (TAK) Japan $42.605B 9.43
Sandoz Group AG (SDZNY) Switzerland $21.019B 0.00
Merck (MKKGY) Germany $19.580B 17.53
Astellas Pharma (ALPMY) Japan $17.518B 16.13
Summit Therapeutics (SMMT) United States $15.855B 0.00
United Therapeutics (UTHR) United States $15.678B 15.42
Neurocrine Biosciences (NBIX) United States $15.371B 40.70
Shionogi (SGIOY) Japan $12.999B 0.00
Orion OYJ (ORINY) Finland $7.681B 21.59
Madrigal Pharmaceuticals (MDGL) United States $7.302B 0.00
Corcept Therapeutics (CORT) United States $7.012B 53.11
Stevanato Group S.p.A (STVN) Italy $6.787B 43.94
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.911B 0.00
Ionis Pharmaceuticals (IONS) United States $5.037B 0.00
Grifols, S.A (GRFS) Spain $4.737B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.331B 6.88
Crinetics Pharmaceuticals (CRNX) United States $3.737B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.829B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.691B 12.19
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.559B 15.30
Centessa Pharmaceuticals (CNTA) United Kingdom $2.231B 0.00
Soleno Therapeutics (SLNO) United States $2.166B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.059B 0.00
Hypermarcas (HYPMY) Brazil $1.957B 0.00
Indivior (INDV) United States $1.641B 6.69
BioCryst Pharmaceuticals (BCRX) United States $1.636B 0.00
Evotec AG (EVO) Germany $1.602B 0.00
Dyne Therapeutics (DYN) United States $1.447B 0.00
Guardian Pharmacy Services (GRDN) United States $1.444B 0.00
Xencor (XNCR) United States $1.279B 0.00
Ardelyx (ARDX) United States $1.270B 0.00
ARS Pharmaceuticals (SPRY) United States $1.265B 0.00
Ocular Therapeutix (OCUL) United States $1.211B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.138B 0.00
Harrow (HROW) United States $1.094B 0.00
Enliven Therapeutics (ELVN) United States $1.068B 0.00
Collegium Pharmaceutical (COLL) United States $1.036B 5.65
Bioventus (BVS) United States $0.867B 27.39
Avadel Pharmaceuticals (AVDL) Ireland $0.761B 0.00
Relay Therapeutics (RLAY) United States $0.748B 0.00
Cronos Group (CRON) Canada $0.726B 0.00
Verve Therapeutics (VERV) United States $0.644B 0.00
USANA Health Sciences (USNA) United States $0.621B 11.51
Elite Pharmaceuticals (ELTP) United States $0.534B 0.00
Xeris Biopharma Holdings (XERS) United States $0.531B 0.00
Akebia Therapeutics (AKBA) United States $0.489B 0.00
ProKidney (PROK) United States $0.481B 0.00
Altimmune (ALT) United States $0.472B 0.00
Oruka Therapeutics (ORKA) United States $0.471B 0.00
Savara (SVRA) United States $0.463B 0.00
Organogenesis (ORGO) United States $0.463B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.461B 0.00
OmniAb (OABI) United States $0.455B 0.00
KalVista Pharmaceuticals (KALV) United States $0.440B 0.00
Siga Technologies (SIGA) United States $0.427B 4.98
Zevra Therapeutics (ZVRA) United States $0.418B 0.00
Tourmaline Bio (TRML) United States $0.412B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.381B 154.64
Ironwood Pharmaceuticals (IRWD) United States $0.374B 0.00
Esperion Therapeutics (ESPR) United States $0.353B 0.00
Korro Bio (KRRO) United States $0.320B 0.00
Aldeyra Therapeutics (ALDX) United States $0.312B 0.00
Aquestive Therapeutics (AQST) United States $0.275B 0.00
4D Molecular Therapeutics (FDMT) United States $0.259B 0.00
Heron Therapeutics (HRTX) United States $0.259B 0.00
Nature's Sunshine Products (NATR) United States $0.257B 15.29
Amylyx Pharmaceuticals (AMLX) United States $0.250B 0.00
Larimar Therapeutics (LRMR) United States $0.245B 0.00
Innate Pharma SA (IPHYF) France $0.243B 0.00
CytoDyn (CYDY) United States $0.243B 0.00
Avita Medical (RCEL) United States $0.239B 0.00
MediWound (MDWD) Israel $0.211B 0.00
Profound Medical (PROF) Canada $0.194B 0.00
Acrivon Therapeutics (ACRV) United States $0.189B 0.00
Lexeo Therapeutics (LXEO) United States $0.180B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.179B 0.00
Aclaris Therapeutics (ACRS) United States $0.177B 0.00
Lyell Immunopharma (LYEL) United States $0.172B 0.00
Nanobiotix S.A (NBTX) France $0.164B 0.00
Silence Therapeutics (SLN) United Kingdom $0.160B 0.00
Inhibikase Therapeutics (IKT) United States $0.157B 0.00
VAXART, INC (VXRT) United States $0.155B 0.00
Nektar Therapeutics (NKTR) United States $0.153B 0.00
Champions Oncology (CSBR) United States $0.152B 0.00
Telomir Pharmaceuticals (TELO) United States $0.144B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.119B 0.00
Cardiol Therapeutics (CRDL) Canada $0.116B 0.00
Cassava Sciences (SAVA) United States $0.115B 0.00
Achieve Life Sciences (ACHV) Canada $0.112B 0.00
Inotiv (NOTV) United States $0.111B 0.00
ElectroCore (ECOR) United States $0.111B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.109B 0.00
Protara Therapeutics (TARA) United States $0.102B 0.00
Metagenomi (MGX) United States $0.101B 0.00
Journey Medical (DERM) United States $0.095B 0.00
Pyxis Oncology (PYXS) United States $0.093B 0.00
Nutriband (NTRB) United States $0.092B 0.00
Fractyl Health (GUTS) United States $0.089B 0.00
Avalo Therapeutics (AVTX) United States $0.088B 0.00
Arch Biopartners (ACHFF) Canada $0.082B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.080B 0.00
AleAnna (ANNA) United States $0.080B 0.00
Karyopharm Therapeutics (KPTI) United States $0.079B 0.00
Galectin Therapeutics (GALT) United States $0.078B 0.00
Assertio Holdings (ASRT) United States $0.077B 20.07
ESSA Pharma (EPIX) Canada $0.076B 0.00
PMV Pharmaceuticals (PMVP) United States $0.073B 0.00
Century Therapeutics (IPSC) United States $0.070B 0.00
Context Therapeutics (CNTX) United States $0.069B 0.00
Regulus Therapeutics (RGLS) United States $0.066B 0.00
Mural Oncology (MURA) Ireland $0.064B 0.00
Unicycive Therapeutics (UNCY) United States $0.064B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.063B 0.00
Prelude Therapeutics (PRLD) United States $0.061B 0.00
OptiNose (OPTN) United States $0.060B 0.00
Gain Therapeutics (GANX) United States $0.057B 0.00
Rafael Holdings (RFL) United States $0.051B 0.00
FibroGen (FGEN) United States $0.049B 0.00
NRx Pharmaceuticals (NRXP) United States $0.047B 0.00
AlloVir (ALVR) United States $0.047B 0.00
Iterum Therapeutics (ITRM) Ireland $0.044B 0.00
SCYNEXIS (SCYX) United States $0.041B 0.00
Tempest Therapeutics (TPST) United States $0.040B 0.00
CASI Pharmaceuticals (CASI) China $0.038B 0.00
Surrozen (SRZN) United States $0.038B 0.00
VYNE Therapeutics (VYNE) United States $0.035B 0.00
Jupiter Neurosciences (JUNS) United States $0.034B 0.00
Scienture Holdings (SCNX) United States $0.034B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.032B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.030B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.030B 0.00
Incannex Healthcare (IXHL) Australia $0.029B 0.00
BioVie (BIVI) United States $0.029B 0.00
PolyPid (PYPD) Israel $0.029B 0.00
Natural Alternatives (NAII) United States $0.027B 0.00
Traws Pharma (TRAW) United States $0.027B 0.00
DURECT (DRRX) United States $0.024B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Vivos Therapeutics (VVOS) United States $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Lipocine (LPCN) United States $0.023B 0.00
Dominari Holdings (DOMH) United States $0.022B 0.00
Mannatech (MTEX) United States $0.022B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.020B 0.00
Carisma Therapeutics (CARM) United States $0.019B 0.00
MEI Pharma (MEIP) United States $0.019B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
Cosmos Health (COSM) United States $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.016B 0.00
TherapeuticsMD (TXMD) United States $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Nuvilex (PMCB) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
Relmada Therapeutics (RLMD) United States $0.011B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Klotho Neurosciences (KLTO) United States $0.010B 0.00
Ainos (AIMD) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.010B 0.00
Indaptus Therapeutics (INDP) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Redhill Biopharma (RDHL) Israel $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
BioLineRx (BLRX) Israel $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
ProPhase Labs (PRPH) United States $0.006B 0.00
Viracta Therapeutics (VIRX) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Clearmind Medicine (CMND) Canada $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.005B 0.00
Bio-Path Holdings (BPTH) United States $0.005B 0.00
SciSparc (SPRC) Israel $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.07
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00